Idiopathic Retroperitoneal Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Retroperitoneal Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis [Phase 2, Phase 3]
An ongoing Phase 2/Phase 3 clinical trial is evaluating sirolimus for idiopathic retroperitoneal fibrosis, with recruitment currently ongoin…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis [Phase 4]
This clinical trial update notes a Phase 4 study evaluating early discontinuation of steroid treatment in patients with Idiopathic Retroperi…
-
CLINICAL_TRIALS research · 2010-11-15Clinical Trial Update: Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial [Phase 3]
A Phase 3 randomized multicenter trial is evaluating methotrexate as a steroid-sparing treatment for idiopathic retroperitoneal fibrosis, wi…
-
CLINICAL_TRIALS research · 2007-02-27Clinical Trial Update: Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis [Phase 2]
Phase 2 clinical trial comparing prednisone and tamoxifen for idiopathic retroperitoneal fibrosis is ongoing. The current trial status is no…